MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
MEDIFAST INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$12.03+0.15 (+1.26%)
Close on Oct 19, 2026
- Market cap
- $133.95M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
MEDIFAST INC revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 17 | Q3 17 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optavia Segment | $76.38M | $76.04M | $75.10M | $89.41M | $105.56M | $115.73M | $119.00M | $140.16M | $168.56M | $174.74M | – | – | 100.0% | -27.6% |
| Medifast Direct [Member] | – | – | – | – | – | – | – | – | – | – | $6.59M | $7.79M | – | – |
| MWCC [Member] | – | – | – | – | – | – | – | – | – | – | $2.59M | $2.76M | – | – |
| Medifast Wholesale [Member] | – | – | – | – | – | – | – | – | – | – | $218.00K | $222.00K | – | – |
| Optavia [Member] | – | – | – | – | – | – | – | – | – | – | $68.61M | $66.43M | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Medifast's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.